Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Verrucarin A is a macrocyclic trichothecene that has been found in M. verrucaria and has diverse biological activities.1,2,3,4 It induces apoptosis and production of reactive oxygen species (ROS) in MDA-MB-231 and T47D breast cancer cells when used at concentrations ranging from 100 to 500 ng/ml.1 Verrucarin A enhances LPS-induced secretion of IL-1β and IL-18 in macrophage-differentiated peripheral blood mononuclear cells (PBMCs).2 It inhibits the growth of the multidrug-resistant P. falciparum strain K1 (EC50 = 0.9 ng/ml).3 Verrucarin A is active against M. incognita root-knot nematodes (MIC = 1.88 µg/ml).4
WARNING This product is not for human or veterinary use.
1. Verrucarin A, a protein synthesis inhibitor, induces growth inhibition and apoptosis in breast cancer cell lines MDA-
2. Trichothecene mycotoxins activate inflammatory response in human macrophages. J. Immunol. 182(10), 6418-6425 (2009).
3. Antimalarial activity of macrocyclic trichothecenes isolated from the fungus Myrothecium verrucaria. J. Nat. Prod. 62(2), 329-331 (1999).
4. Nematicidal activity of verrucarin A and roridin A isolated from Myrothecium verrucaria against Meloidogyne incognita. Pestic. Biochem. Physiol. 148, 133-143 (2018).
Empagliflozin (Jardiance): A novel SGLT2 inhibitor for the treatment of type-